Category: Licensing/Collaboration Deal Region: Europe · France Company: Novasep Sas

McSAF and Novasep announce their successful collaboration to produce a next-generation Antibody-Drug Conjugate

McSAF and Novasep announce their successful collaboration to produce a next-generation Antibody-Drug Conjugate
Novasep, a leading supplier of services and technologies for the life sciences industry, and McSAF, a French biotech based in Tours, specialized in bioconjugation tools to design innovative and efficient bio drugs for health and diagnostics, are pleased to announce their successful collaboration for the preclinical production of ADCITMER

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!